Holista have put up the full detailed test results on their website:
https://www.holistaco.com/pdf/asx-2020/COVID-19-MiCROBAC-1029-102.pdf
Looks pretty good overall.
Summary of important sections below:
Test was sponsored by GICC / Dr. Arthur
Test Organism: SARS-CoV-2, COVID-19 Virus Strain: USA-WA 1/2020, undiluted 5% FBS load
Test Method: Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces
Test Substance: Path-away aerosol solution
Active Ingredients: Citrus Extract, Ascorbic Acid, Glycerine
Surface used: Glass
Test Substance Application and Exposure Conditions: 2.0 mL of test substance was added to the dried virus inoculum and held for the contact time of 2 minutes and 5 minutes at 21°C with 53% RH.
TEST ACCEPTANCE CRITERIA
The test was considered acceptable for test substance evaluation due to the criteria below being satisfied:
- The infectious virus recovered from the PRC was ≥ 4.8 Log10 TCID50 units.
- Viral-induced CPE was distinguishable from test substance induced cytotoxicity (if any).
- Virus was recovered from dilutions of the NE/VI control not exhibiting cytotoxicity.
- The CVC did not exhibit CPE.
TEST SUBSTANCE EVALUATION CRITERIA
- According to the US Environmental Protection Agency, the test substance passes the test if the following criteria are met:
- The test substance must demonstrate a ≥ 3 Log10 reduction on each test carrier in the presence or absence of cytotoxicity. If cytotoxicity is present, the virus control titer should be sufficient to demonstrate a ≥ 3 Log10 reduction in viral titer on each test carrier beyond the level of cytotoxicity.
CONCLUSIONS
- When tested as described, PATH-AWAY ANTI-PATHOGENIC AEROSOL SOLUTION, Lot Nos. 22020, 42020, and 52020, passed the Virucidal Hard-Surface Efficacy Test when Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) (COVID-19 Virus), containing 5.0%
- FBS, was exposed to the test substance for 2 minutes and 5 minutes at 21°C and 53% RH. All controls met the criteria for a valid test. These conclusions are based on observed data.
Questions that need answering:
- If the active ingredients a simple combo of the 3 things listed, what's stopping other players making it?
- Do GICC / Holista have any patents / registered trademarks to protect against above?
- Forums
- ASX - By Stock
- HCT
- Path-away Microbac Test Results summary
Path-away Microbac Test Results summary
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.788M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
HCT (ASX) Chart |
Day chart unavailable